C Ventures, a VC firm set up by Adrian Cheng, scion of Hong Kong’s New World Development, has rebranded as C Capital – reflecting steps to diversify into a multi-strategy asset manager – and reached a first close on its latest fund.
The firm was founded in 2017, with its first fund acting essentially as a family office for Cheng. A second vehicle closed in 2019, attracting some third-party capital. Fund III has a target of USD 300m...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.